Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

• Venkata Raghava Mohan,

  Roles Writing – review & editing

  Affiliation Christian Medical College, Vellore, India

  ⨯
• Santosh Raj,

  Roles Writing – review & editing

  Affiliation Christian Medical College, Vellore, India

  ⨯
• Mandeep Singh Dhingra,

  Roles Conceptualization, Writing – review & editing

  Affiliation Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America

  ⨯
• Naveena Aloysia D’Cor ,

  Roles Writing – review & editing

  * E-mail: Naveena.Aloysia@sanofi.com

  Affiliation Shantha Biotechnics Private Limited, Hyderabad, India

  http://orcid.org/0000-0002-2930-9322

  ⨯
• Ajit Pal Singh,

  Roles Writing – review & editing

  Affiliation International Vaccine Institute, Seoul, South Korea

  ⨯
• Tarun Saluja,

  Roles Writing – review & editing

  Affiliation International Vaccine Institute, Seoul, South Korea

  ⨯
• Deok Ryun Kim,

  Roles Writing – review & editing

  Affiliation International Vaccine Institute, Seoul, South Korea

  ⨯
• Venkat Jayanth Midde,

  Roles Conceptualization, Writing – review & editing

  Affiliation Shantha Biotechnics Private Limited, Hyderabad, India

  ⨯
• Yanghee Kim,

  Roles Conceptualization, Writing – review & editing

  Affiliation International Vaccine Institute, Seoul, South Korea

  ⨯
• Sridhar Vemula,

  Roles Writing – review & editing

  Affiliation Shantha Biotechnics Private Limited, Hyderabad, India

  ⨯
• Santhosh Kumar Narla,

  Roles Writing – review & editing

  Affiliation Shantha Biotechnics Private Limited, Hyderabad, India

  ⨯
• Binod Sah,

  Roles Writing – review & editing

  Affiliation International Vaccine Institute, Seoul, South Korea

  ⨯
• Mohammad Ali

  Roles Writing – review & editing

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯